Doron Breen

Doron Breen has filed trades across 2 companies (mainly through SEC (Form 4)), most often in NeurogesX Inc and Orexigen Therapeutics, Inc. Between 11 September 2009 and 10 August 2011, the trades on record add up to 83 filings.

In open-market terms, that means 50 purchases worth €3.6M on one side and 33 sales worth €3.0M on the other. Purchases outweigh sales by €637k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2011 alone, the filings show no purchases and 26 sales.

In size, the median ticket on the buying side is €40k.

Most recently, on 11 August 2011, the filings show an open-market sale worth €122k in NeurogesX Inc. The latest purchase dates back some time: it was published 5,931 days ago, on 29 July 2010. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.